1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Imports
  5. Import of Penicillins or…

Import of penicillins or streptomycins not in dosage forms to Belize: Fall in 2016

Pharmaceutical import greatly declined by 91.75% in comparison with the same time an year ago, according to updated numbers issued by United Nations Statistical Office. The indicator dropped strongly by 11 355 US Dollar, contrarily to the prior year when it rose by 394.84%. The overall changes for the previous 25 years hit a decrease of 98.9%. Furthermore, it has had a drop at a 0.25 percent compound annual growth rate during the last 5 years with a negligible overall fall since the start of observations. It averaged 30 977.36 US Dollar from 1992 to 2016 and it attained its all-time high of 134 605 US Dollar in 1997 and record low of 55 US Dollar in 1999.

Import of penicillins or streptomycins not in dosage forms to Belize: Fall in 2016
Date US Dollar Variation
2016 1 021.00 -91.75
2015 12 376.00 394.84
2014 2 501.00 -72.67
2013 9 152.00 115.09
2012 4 255.00 0.85
2011 4 219.00 16.29
2010 3 628.00 2271.24
2009 153.00 77.91
2008 86.00 -98.97
2007 8 356.00 189.74

Related Statistics

Pharmaceutical Imports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales